Mazen R Al-Mansour1, Antonio Caycedo-Marulanda2, Brian R Davis3, Abdulrahim Alawashez4, Salvatore Docimo5, Alia Qureshi6, Shawn Tsuda7. 1. Department of Surgery, University of Florida, Gainesville, FL, USA. mazen.al-mansour@surgery.ufl.edu. 2. Queen's University, Kingston, ON, Canada. 3. Texas Tech Paul L Foster School of Medicine, El Paso, TX, USA. 4. University Hospital Sharjah, University of Sharjah, Sharjah, UAE. 5. Stony Brook University, Stony Brook, NY, USA. 6. Harvard Medical School, Boston, MA, USA. 7. VIP Surg. PLLC., Las Vegas, NV, USA.
Abstract
BACKGROUND: Confocal laser endomicroscopy (CLE) is a novel endoscopic adjunct that allows real-time in vivo histological examination of mucosal surfaces. By using intravenous or topical fluorescent agents, CLE highlights certain mucosal elements that facilitate an optical biopsy in real time. CLE technology has been used in different organ systems including the gastrointestinal tract. There has been numerous studies evaluating this technology in gastrointestinal endoscopy, our aim was to evaluate the safety, value, and efficacy of this technology in the gastrointestinal tract. METHODS: The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Technology and Value Assessment Committee (TAVAC) performed a PubMed/Medline database search of clinical studies involving CLE in May of 2018. The literature search used combinations of the keywords: confocal laser endomicroscopy, pCLE, Cellvizio, in vivo microscopy, optical histology, advanced endoscopic imaging, and optical diagnosis. Bibliographies of key references were searched for relevant studies not covered by the PubMed search. Case reports and small case series were excluded. The manufacturer's website was also used to identify key references. The United States Food and Drug Administration (U.S. FDA) Manufacturer And User facility and Device Experience (MAUDE) database was searched for reports regarding the device malfunction or injuries. RESULTS: The technology offers an excellent safety profile with rare adverse events related to the use of fluorescent agents. It has been shown to increase the detection of dysplastic Barrett's esophagus, gastric intraepithelial neoplasia/early gastric cancer, and dysplasia associated with inflammatory bowel disease when compared to standard screening protocols. It also aids in the differentiation and classification of colorectal polyps, indeterminate biliary strictures, and pancreatic cystic lesions. CONCLUSIONS: CLE has an excellent safety profile. CLE can increase the diagnostic accuracy in a number of gastrointestinal pathologies.
BACKGROUND: Confocal laser endomicroscopy (CLE) is a novel endoscopic adjunct that allows real-time in vivo histological examination of mucosal surfaces. By using intravenous or topical fluorescent agents, CLE highlights certain mucosal elements that facilitate an optical biopsy in real time. CLE technology has been used in different organ systems including the gastrointestinal tract. There has been numerous studies evaluating this technology in gastrointestinal endoscopy, our aim was to evaluate the safety, value, and efficacy of this technology in the gastrointestinal tract. METHODS: The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Technology and Value Assessment Committee (TAVAC) performed a PubMed/Medline database search of clinical studies involving CLE in May of 2018. The literature search used combinations of the keywords: confocal laser endomicroscopy, pCLE, Cellvizio, in vivo microscopy, optical histology, advanced endoscopic imaging, and optical diagnosis. Bibliographies of key references were searched for relevant studies not covered by the PubMed search. Case reports and small case series were excluded. The manufacturer's website was also used to identify key references. The United States Food and Drug Administration (U.S. FDA) Manufacturer And User facility and Device Experience (MAUDE) database was searched for reports regarding the device malfunction or injuries. RESULTS: The technology offers an excellent safety profile with rare adverse events related to the use of fluorescent agents. It has been shown to increase the detection of dysplastic Barrett's esophagus, gastric intraepithelial neoplasia/early gastric cancer, and dysplasia associated with inflammatory bowel disease when compared to standard screening protocols. It also aids in the differentiation and classification of colorectal polyps, indeterminate biliary strictures, and pancreatic cystic lesions. CONCLUSIONS: CLE has an excellent safety profile. CLE can increase the diagnostic accuracy in a number of gastrointestinal pathologies.
Entities:
Keywords:
Advanced endoscopic imaging; Cellvizio; Confocal laser endomicroscopy; In vivo microscopy; Optical histology; pCLE
Authors: Takeshi Tsujino; Jason Yan-Lin Huang; Yosuke Nakai; Jason B Samarasena; John G Lee; Kenneth J Chang Journal: Best Pract Res Clin Gastroenterol Date: 2015-06-27 Impact factor: 3.043
Authors: Sebastian Foersch; Ralf Kiesslich; Maximillian J Waldner; Peter Delaney; Peter R Galle; Markus F Neurath; Martin Goetz Journal: Gut Date: 2010-08 Impact factor: 23.059
Authors: Pei-Lin Hsiung; Pei-Lei Hsiung; Jonathan Hardy; Shai Friedland; Roy Soetikno; Christine B Du; Amy P Wu; Peyman Sahbaie; James M Crawford; Anson W Lowe; Christopher H Contag; Thomas D Wang Journal: Nat Med Date: 2008-03-16 Impact factor: 53.440
Authors: Matthew B Sturm; Cyrus Piraka; B Joseph Elmunzer; Richard S Kwon; Bishnu P Joshi; Henry D Appelman; D Kim Turgeon; Thomas D Wang Journal: Gastroenterology Date: 2013-05-14 Impact factor: 22.682
Authors: Martin Goetz; Alex Ziebart; Sebastian Foersch; Michael Vieth; Maximilian J Waldner; Peter Delaney; Peter R Galle; Markus F Neurath; Ralf Kiesslich Journal: Gastroenterology Date: 2009-10-21 Impact factor: 22.682
Authors: Z Li; X L Zuo; C Q Li; C J Zhou; J Liu; M Goetz; R Kiesslich; K C Wu; D M Fan; Y Q Li Journal: Endoscopy Date: 2013-01-30 Impact factor: 10.093
Authors: Muhammad W Shahid; Julia E Crook; Alexander Meining; Aymeric Perchant; Anna Buchner; Victoria Gomez; Michael B Wallace Journal: J Interv Gastroenterol Date: 2011-10-01
Authors: M Sakashita; H Inoue; H Kashida; J Tanaka; J Y Cho; H Satodate; E Hidaka; T Yoshida; N Fukami; Y Tamegai; A Shiokawa; S Kudo Journal: Endoscopy Date: 2003-12 Impact factor: 10.093
Authors: Giovanni Domenico De Palma; Irene Colavita; Gerardo Zambrano; Mariano Cesare Giglio; Francesco Maione; Gaetano Luglio; Giovanni Sarnelli; Antonio Rispo; Pietro Schettino; Francesco Paolo D'Armiento; Fatima Domenica Elisa De Palma; Valeria D'Argenio; Francesco Salvatore Journal: PLoS One Date: 2017-06-30 Impact factor: 3.240
Authors: Frank B Sachse; Jordan Johnson; Brian Cottle; Abhijit Mondal; Robert Hitchcock; Aditya K Kaza Journal: Heart Rhythm Date: 2020-07-10 Impact factor: 6.343
Authors: Do Han Kim; Somashekar G Krishna; Emmanuel Coronel; Paul T Kröner; Herbert C Wolfsen; Michael B Wallace; Juan E Corral Journal: Clin Endosc Date: 2021-11-29